Annual Total Expenses:
$800.53M+$167.50M(+26.46%)Summary
- As of today, PCRX annual total expenses is $800.53 million, with the most recent change of +$167.50 million (+26.46%) on December 31, 2024.
- During the last 3 years, PCRX annual total expenses has risen by +$300.97 million (+60.25%).
- PCRX annual total expenses is now at all-time high.
Performance
PCRX Total Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly Total Expenses:
$174.08M-$11.86M(-6.38%)Summary
- As of today, PCRX quarterly total expenses is $174.08 million, with the most recent change of -$11.86 million (-6.38%) on September 30, 2025.
- Over the past year, PCRX quarterly total expenses has dropped by -$137.96 million (-44.21%).
- PCRX quarterly total expenses is now -44.21% below its all-time high of $312.04 million, reached on September 30, 2024.
Performance
PCRX Quarterly Total Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Total Expenses Formula
Total Expenses = Cost of Goods Sold + Operating Expenses + Non Operating Expenses
PCRX Total Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1Y1 Year | +26.5% | -44.2% |
| 3Y3 Years | +60.3% | +3.5% |
| 5Y5 Years | +85.3% | +1477.8% |
PCRX Total Expenses Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | |
|---|---|---|---|---|---|
| 3Y | 3-Year | at high | +60.3% | -44.2% | +21.1% |
| 5Y | 5-Year | at high | +181.8% | -44.2% | +1477.8% |
| All-Time | All-Time | at high | +1819.2% | -44.2% | +1477.8% |
PCRX Total Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2025 | - | $174.08M(-6.4%) |
| Jun 2025 | - | $185.95M(+13.3%) |
| Mar 2025 | - | $164.11M(-4.1%) |
| Dec 2024 | $800.53M(+26.5%) | $171.21M(-45.1%) |
| Sep 2024 | - | $312.04M(+96.1%) |
| Jun 2024 | - | $159.14M(+0.6%) |
| Mar 2024 | - | $158.14M(+1.1%) |
| Dec 2023 | $633.02M(-2.7%) | $156.37M(+2.2%) |
| Sep 2023 | - | $153.07M(+6.5%) |
| Jun 2023 | - | $143.70M(-20.1%) |
| Mar 2023 | - | $179.88M(-1.2%) |
| Dec 2022 | $650.91M(+30.3%) | $182.06M(+8.3%) |
| Sep 2022 | - | $168.16M(+12.5%) |
| Jun 2022 | - | $149.53M(-1.1%) |
| Mar 2022 | - | $151.16M(-8.0%) |
| Dec 2021 | $499.55M(+75.8%) | $164.32M(+49.3%) |
| Sep 2021 | - | $110.06M(-5.5%) |
| Jun 2021 | - | $116.51M(+7.2%) |
| Mar 2021 | - | $108.66M(-6.7%) |
| Dec 2020 | $284.12M(-34.2%) | $116.46M(+1021.7%) |
| Sep 2020 | - | -$12.63M(-115.3%) |
| Jun 2020 | - | $82.77M(-15.1%) |
| Mar 2020 | - | $97.53M(-23.4%) |
| Dec 2019 | $432.04M(+27.9%) | $127.31M(+14.9%) |
| Sep 2019 | - | $110.77M(+10.9%) |
| Jun 2019 | - | $99.87M(+6.2%) |
| Mar 2019 | - | $94.08M(+8.4%) |
| Dec 2018 | $337.75M(+2.6%) | $86.83M(+3.3%) |
| Sep 2018 | - | $84.09M(+3.1%) |
| Jun 2018 | - | $81.54M(-4.4%) |
| Mar 2018 | - | $85.29M(+14.5%) |
| Dec 2017 | $329.24M | $74.48M(-0.6%) |
| Sep 2017 | - | $74.93M(-17.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2017 | - | $90.68M(+1.7%) |
| Mar 2017 | - | $89.15M(+16.0%) |
| Dec 2016 | $314.32M(+27.2%) | $76.88M(-15.1%) |
| Sep 2016 | - | $90.52M(+16.7%) |
| Jun 2016 | - | $77.60M(+11.9%) |
| Mar 2016 | - | $69.33M(+17.3%) |
| Dec 2015 | $247.14M(+16.9%) | - |
| Sep 2015 | - | $59.13M(-0.0%) |
| Jun 2015 | - | $59.14M(+3.7%) |
| Mar 2015 | - | $57.06M(+1.9%) |
| Dec 2014 | $211.38M(+41.4%) | $55.99M(+1.7%) |
| Sep 2014 | - | $55.05M(+5.5%) |
| Jun 2014 | - | $52.20M(+8.4%) |
| Mar 2014 | - | $48.14M(+5.8%) |
| Dec 2013 | $149.46M(+63.6%) | $45.52M(+19.7%) |
| Sep 2013 | - | $38.04M(+22.0%) |
| Jun 2013 | - | $31.17M(-10.2%) |
| Mar 2013 | - | $34.73M(+29.6%) |
| Dec 2012 | $91.36M(+54.8%) | $26.80M(+10.6%) |
| Sep 2012 | - | $24.23M(+17.4%) |
| Jun 2012 | - | $20.64M(+4.8%) |
| Mar 2012 | - | $19.70M(+0.9%) |
| Dec 2011 | $59.02M(+41.5%) | $19.52M(+44.9%) |
| Sep 2011 | - | $13.46M(+8.6%) |
| Jun 2011 | - | $12.40M(-9.1%) |
| Mar 2011 | - | $13.64M(+47.7%) |
| Dec 2010 | $41.71M(-10.7%) | $9.23M(-61.6%) |
| Sep 2010 | - | $24.06M(+177.1%) |
| Jun 2010 | - | $8.68M(-7.6%) |
| Mar 2010 | - | $9.40M(-22.3%) |
| Dec 2009 | $46.71M(-16.3%) | $12.09M(+22.4%) |
| Sep 2009 | - | $9.88M |
| Dec 2008 | $55.79M(+25.3%) | - |
| Dec 2007 | $44.53M | - |
FAQ
- What is Pacira BioSciences, Inc. annual total expenses?
- What is the all-time high annual total expenses for Pacira BioSciences, Inc.?
- What is Pacira BioSciences, Inc. annual total expenses year-on-year change?
- What is Pacira BioSciences, Inc. quarterly total expenses?
- What is the all-time high quarterly total expenses for Pacira BioSciences, Inc.?
- What is Pacira BioSciences, Inc. quarterly total expenses year-on-year change?
What is Pacira BioSciences, Inc. annual total expenses?
The current annual total expenses of PCRX is $800.53M
What is the all-time high annual total expenses for Pacira BioSciences, Inc.?
Pacira BioSciences, Inc. all-time high annual total expenses is $800.53M
What is Pacira BioSciences, Inc. annual total expenses year-on-year change?
Over the past year, PCRX annual total expenses has changed by +$167.50M (+26.46%)
What is Pacira BioSciences, Inc. quarterly total expenses?
The current quarterly total expenses of PCRX is $174.08M
What is the all-time high quarterly total expenses for Pacira BioSciences, Inc.?
Pacira BioSciences, Inc. all-time high quarterly total expenses is $312.04M
What is Pacira BioSciences, Inc. quarterly total expenses year-on-year change?
Over the past year, PCRX quarterly total expenses has changed by -$137.96M (-44.21%)